Charlie Schmidt. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/pharmacologyAntigens, CD/drug effectsAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useCTLA-4 AntigenCancer Vaccines/pharmacologyCancer Vaccines/therapeutic useFemaleHumansImmunotherapy/methodsImmunotherapy, Adoptive/methodsLiver Neoplasms/prevention & controlLiver Neoplasms/virologyMelanoma/drug therapyMelanoma/immunologyMelanoma/prevention & controlSkin Neoplasms/drug therapySkin Neoplasms/immunologySkin Neoplasms/prevention & controlUterine Cervical Neoplasms/prevention & controlUterine Cervical Neoplasms/virology
Substances: See more » Antibodies, MonoclonalAntigens, CDAntineoplastic AgentsCTLA-4 AntigenCTLA4 protein, humanCancer Vaccines
Year: 2009 PMID: 19176461 DOI: 10.1093/jnci/djn508
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506